When to take it out? Optimal timing of interval appendectomy in 500 consecutive children

Bethany J Farr1, Denston E Carey2, David P Mooney3

  • 1Department of Surgery, Boston Children's Hospital, Boston, MA, USA.

Insights

Performing interval appendectomy before 12 weeks after perforated appendicitis may increase the risk of acute inflammation, leading to longer operative times. This finding is crucial for optimizing surgical timing after nonoperative management.

Area of Science:

  • Pediatric Surgery
  • Gastrointestinal Surgery
  • Surgical Outcomes Research

Background:

  • Interval appendectomy is a delayed surgical procedure after nonoperative management of perforated appendicitis.
  • The optimal timing for interval appendectomy remains unclear, impacting patient care and surgical planning.

Purpose of the Study:

  • To determine the optimal time interval between presentation of perforated appendicitis and subsequent interval appendectomy.
  • To investigate the association between the timing of interval appendectomy and pathological findings, specifically acute inflammation.

Main Methods:

  • A retrospective review of 500 patients who underwent interval appendectomy between 2006 and 2019 at a children's hospital.
  • Data analysis included demographics, hospitalization details, and pathology reports, utilizing t-tests and logistic regression.

Main Results:

  • Operations performed before 12 weeks post-presentation were associated with a two-fold increased odds of acute inflammation (p < 0.01).
  • Acute inflammation correlated with significantly longer operative times (mean 101 vs. 84 minutes, p < 0.01).
  • Factors like appendicolith presence, hospitalization length, drain placement, readmission, age, and gender did not predict acute inflammation.

Conclusions:

  • Acute inflammation can persist for many weeks after appendicitis perforation and is linked to increased operative time.
  • Performing interval appendectomy earlier than 12 weeks increases the likelihood of encountering acute inflammation.
Abstract

Related Concept Videos

Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
283
Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
112
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
111